| This paper seems to describe the general strategy: Neuronal regulation of the gut immune system and neuromodulation for treating inflammatory bowel disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565205/ It would be incredible if it works, since it would avoid treatment with systemic immunosuppresives which can promote infection/cancer. However maybe there is still a local risk of the above? I would also be concerned about the implant getting covered in nasty biofilms over time. If this type of thing works, does that mean that medication that target the nerves might work against inflammatory disease? |
Note that while TNF inhibitors like adalimumab (Humira) have a black box cancer warning in the US, this was based on assessing a small number of studies early on. We now have more than 20 years of studies and patient registry data, and later studies, including meta-analyses, have concluded that there is no additional risk of cancer with these TNF inhibitors.
E.g. see:
https://pubmed.ncbi.nlm.nih.gov/24361468/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770105/